Antisense Oligonucleotide-conjugated Nanostructure Targeting LncRNA MALAT1 Inhibits Cancer Metastasis.

Ningqiang Gong,Xucong Teng,Jinghong Li,Xing-Jie Liang
DOI: https://doi.org/10.1021/acsami.8b18288
IF: 9.5
2019-01-01
ACS Applied Materials & Interfaces
Abstract:Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), a long noncoding RNA (lncRNA) located in the cell nucleus, is a critical regulator of tumor cell migration. Antisense oligonucleotides (ASOs), which can downregulate the expression level of specific RNAs, have been used in clinical for diseases treatment. Herein, we constructed MALAT1-specific ASO and nucleus-targeting TAT peptide co-functionalized Au nanoparticles, namely ASO-Au-TAT NPs, which stabilized the fragile ASOs, enhanced nuclear internalization, and exhibited good biocompatibility. After treated with the ASO-Au-TAT NPs, A549 lung cancer cells showed a greatly reduced MALAT1 expression level and decreased migration ability in vitro. Moreover, the ASO-Au-TAT NPs significantly reduced metastatic tumor nodules formation in vivo. Our results demonstrate that the ASO-Au-TAT NSs have great potential for treatment of cancer metastasis.
What problem does this paper attempt to address?